50
Views
14
CrossRef citations to date
0
Altmetric
Radiation Oncology

Intensity Modulated Radiation Therapy (IMRT) in the Management of Prostate Cancer

, M.D., , M.D., , M.D., , M.D., , Ph.D. & , M.D.
Pages 913-924 | Published online: 23 Nov 2004

References

  • Smit W. G., Helle P. A., van Putten W. L., Wijnmaalen A. J., Seldenrath J. J., van der Werf-Messing B. H. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int. J. Radiat. Oncol. Biol. Phys. 1990; 18: 23–29, [PUBMED], [INFOTRIEVE]
  • Lawton C. A., Won M., Pilepich M. V., Asbell S. O., Shipley W. U., Hanks G. E., Cox J. D., Perez C. A., Sause W. T., Doggett S. R., Rubin P. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int. J. Radiat. Oncol. Biol. Phys. 1991; 21(4)935–939, [PUBMED], [INFOTRIEVE]
  • Shipley W. U., Verhey L. J., Munzenrider J. E., Suit H. D., Urie M. M., McManus P. L., Young R. L., Shipley J. W., Zietman A. L., Biggs P. J., Heney N. M., Goitein M. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int. J. Radiat. Oncol. Biol. Phys. 1995; 32(1)3–12, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Slater J. D., Yonemoto L. T., Rossi C. J., Jr., Reyes-Molyneux N. J., Bush D. A., Antoine J. E., Loredo L. N., Schulte R. W., Teichman S. L., Slater J. M. Conformal proton therapy for prostate carcinoma. Int.J. Radiat. Oncol. Biol. Phys. 1998; 42(2)299–304, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Pollack A., Zagars G. K., Starkschall G., Antolak J. A., Lee J. J., Huang E., von Eschenbach A. C., Kuban D. A., Rosen I. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 2002; 53: 1097–1105, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Pollack A., Zagars G. K., Starkschall G., Childress C. H., Kopplin S., Boyer A. L., Rosen I. I. Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. Int. J. Radiat. Oncol. Biol. Phys. 1996; 34: 555–564, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Hanks G. E., Hanlon A. L., Epstein B., Horwitz E. M. Dose response in prostate cancer with 8–12 years' follow-up. Int. J. Radiat. Oncol. Biol. Phys. 2002; 54: 427–435, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Kupelian P. A., Mohan D. S., Lyons J., Klein E. A., Reddy C. A. Higher than standard radiation doses (> or = 72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2002; 46: 567–574, [CROSSREF], [CSA]
  • Zelefsky M. J., Leibel S. A., Gaudin P. B., Kutcher G. J., Fleshner N. E., Venkatramen E. S., Reuter V. E., Fair W. R., Ling C. C., Fuks Z. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 1998; 41: 491–500, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Pollack A., Zagars G. K. External beam radiotherapy dose response of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 1997; 39: 1011–1018, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Dearnaley D. P., Khoo V. S., Norman A. R., Meyer L., Nahum A., Tait D., Yarnold J., Horwich A. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 1999; 353: 267–272, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Koper P. C., Stroom J. C., van Putten W. L., Korevaar G. A., Heijmen B. J., Wijnmaalen A., Jansen P. P., Hanssens P. E., Griep C., Krol A. D., Samson M. J., Levendag P. C. Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study. Int. J. Radiat. Oncol. Biol. Phys. 1999; 43: 727–734, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Oh C. E., Antes K., Darby M., Song S., Starkschall G. Comparison of 2D conventional, 3D conformal, and intensity-modulated treatment planning techniques for patients with prostate cancer with regard to target-dose homogeneity and dose to critical, uninvolved structures. Med. Dosim. 1999; 24: 255–263, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • De Meerleer G. O., Vakaet L. A., De Gersem W. R., De Wagter C., De Naeyer B., De Neve W. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. Int. J. Radiat. Oncol. Biol. Phys. 2000; 47: 639–648, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Zelefsky M. J., Fuks Z., Happersett L., Lee H. J., Ling C. C., Burman C. M., Hunt M., Wolfe T., Venkatraman E. S., Jackson A., Skwarchuk M., Leibel S. A. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother. Oncol. 2000; 55: 241–249, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • King C. R., DiPetrillo T. A., Wazer D. E. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models. Int. J. Radiat. Oncol. Biol. Phys. 2000; 46: 165–172, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Teh B. S., Woo S. Y., Butler E. B. Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology. Oncologist 1999; 4: 433–442, [PUBMED], [INFOTRIEVE], [CSA]
  • Purdy J. A. Intensity-modulated radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1996; 35: 845–846, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Teh B. S., Mai W. Y., Grant W. H., III, Chiu J. K., Lu H. H., Carpenter L. S., Woo S. Y., Butler E. B. Intensity modulated radiotherapy (IMRT) decreases treatment-related morbidity and potentially enhances tumor control. Cancer Invest. 2000; 20: 437–451, [CROSSREF], [CSA]
  • Chui C. S., Chan M. F., Yorke E., Spirou S., Ling C. C. Delivery of intensity-modulated radiation therapy with a conventional multileaf collimator: comparison of dynamic and segmental methods. Med. Phys. 2001; 28: 2441–2449, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Teh B. S., Woo S. Y., Mai W. Y., McGary J. E., Carpenter L. S., Lu H. H., Chiu J. K., Vlachaki M. T., Grant W. H., III, Butler E. B. Clinical experience with intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of rectal balloon for prostate immobilization. Med. Dosim. 2002; 27: 105–113, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Antolak J. A., Rosen I. I., Childress C. H., Zagars G. K., Pollack A. Prostate target volume variations during a course of radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1998; 42: 661–672, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Balter J. M., Sandler H. M., Lam K., Bree R. L., Lichter A. S., ten Haken R. K. Measurement of prostate movement over the course of routine radiotherapy using implanted markers. Int. J. Radiat. Oncol. Biol. Phys. 1995; 31: 113–118, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Beard C. J., Kijewski P., Bussiere M., Gelman R., Gladstone D., Shaffer K., Plunkett M., Castello P., Coleman C. N. Analysis of prostate and seminal vesicle motion: implications for treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 1996; 34: 451–458, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Melian E., Mageras G. S., Fuks Z., Leibel S. A., Niehaus A., Lorant H., Zelefsky M., Baldwin B., Kutcher G. J. Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 1997; 38: 73–81, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Roeske J. C., Forman J. D., Mesina C. F., He T., Pelizzari C. A., Fontenla E., Vijayakumar S., Chen G. T. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1995; 33: 1321–1329, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Teh B. S., Greco S. C., Berner B. M., Dzuik T. D., Grant W. H., III, Thornby J. I., Carpenter L. S., Lu H. H., Chiu J. K., Woo S. Y., Butler E. B. Prostate movement: a function of shift and rotation. J. Brachyther. Int. 2000; 16: 199–206, [CSA]
  • Malone S., Donker R., Broader M., Dahrouge S., Szanto J., Gerig L., Bociek G., Crook J. Effects of urethrography on prostate position: considerations for radiotherapy treatment planning of prostate carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2000; 46: 89–93, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Dawson L. A., Litzenberg D. W., Brock K. K., Sanda M., Sullivan M., Sandler H. M., Balter J. M. A comparison of ventilatory prostate movement in four treatment positions. Int. J. Radiat. Oncol. Biol. Phys. 2000; 48: 319–323, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Ten Haken R. K., Forman J. D., Heimburger D. K., Gerhardsson A., McShan D. L., Perez-Tamayo C., Schoeppel S. L., Lichter A. S. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int. J. Radiat. Oncol. Biol. Phys. 1991; 20: 1317–1324, [PUBMED], [INFOTRIEVE]
  • Langen K. M., Jones D. T. Organ motion and its management. Int. J. Radiat. Oncol. Biol. Phys. 2001; 50: 265–278, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Morr J., DiPetrillo T., Tsai J. S., Engler M., Wazer D. E. Implementation and utility of a daily ultrasound-based localization system with intensity-modulated radiotherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2002; 53: 1124–1129, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Lattanzi J., McNeeley S., Pinover W., Horwitz E., Das I., Schultheiss T. E., Hanks G. E. A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 1999; 43: 719–725, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Bakai A., Paulsen F., Plasswilm L., Bamberg M., Nusslin F. Positioning accuracy in conformational prostatic irradiation using portal imaging. Strahlenther. Onkol. 2002; 178: 84–90, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Balter J. M., Lam K. L., Sandler H. M., Littles J. F., Bree R. L., Ten Haken R. K. Automated localization of the prostate at the time of treatment using implanted radiopaque markers: technical feasibility. Int. J. Radiat. Oncol. Biol. Phys. 1995; 33: 1281–1286, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Vigneault E., Pouliot J., Laverdiere J., Roy J., Dorion M. Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. Int. J. Radiat. Oncol. Biol. Phys. 1997; 37: 205–212, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • McGary J. E., Teh B. S., Butler E. B., Grant W., III. Prostate immobilization using a rectal balloon. J. Appl. Clin. Med. Phys. 2002; 3: 6–11, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • McGary J. E., Grant W., III. A clinical evaluation of setup errors for a prostate immobilization system. J. Appl. Clin. Med. Phys. 2000; 1: 138–147, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • D'Amico A. V., Manola J., Loffredo M., Lopes L., Nissen K., O'Farrell D. A., Gordon L., Tempany C. M., Cormack R. A. A practical method to achieve prostate gland immobilization and target verification for daily treatment. Int. J. Radiat. Oncol. Biol. Phys. 2001; 51: 1431–1436, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Brenner D. J., Hall E. J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 1999; 43: 1095–1101, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Teh B. S., Bastasch M. C., Wheeler T. M., Mai W. Y., Frolof A., Uhl B. M., Lu H. H., Carpenter L. S., Chiu J. K., McGary J., Woo S. Y., Grant W. H., III, Butler E. B. IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease. Int. J. Radiat. Oncol. Biol. Phys. 2003; 56(1)184–191, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Teh B. S., Bastasch M. D., Wheeler T. M., Mai W. Y., Frolov A., Uhl B. M., Lu H. H., Carpenter L. S., Chiu J. K., McGary J., Woo S. Y., Grant W. H., III, Butler E. B. IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease. Int. J. Radiat. Oncol. Biol. Phys. 2003; 56(1)184–191, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Teh B. S., McGary J. E., Dong L., Mai W. Y., Carpenter L. S., Lu H. H., Chiu J. K., Woo S. Y., Grant W. H., III, Butler E. B. The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer—more than just a prostate gland immobilization device?. Cancer J. 2002; 8(6)476–483, [PUBMED], [INFOTRIEVE]
  • Butler E. B., Teh B. S., Grant W. H., III, Uhl B. M., Kuppersmith R. B., Chiu J. K., Donovan D. T., Woo S. Y. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1999; 45: 21–32, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Mohan R., Wu Q., Manning M., Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int. J. Radiat. Oncol. Biol. Phys. 2000; 46: 619–630, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Leibel S. A., Fuks Z., Zelefsky M. J., Wolden S. L., Rosenzweig K. E., Alektiar K. M., Hunt M. A., Yorke E. D., Hong L. X., Amols H. I., Burman C. M., Jackson A., Mageras G. S., LoSasso T., Happersett L., Spirou S. V., Chui C. S., Ling C. C. Intensity-modulated radiotherapy. J. Cancer 2002; 8: 164–176
  • Burman C., Chui C. S., Kutcher G., Leibel S., Zelefsky M., LoSasso T., Spirou S., Wu Q., Yang J., Stein J., Mohan R., Fuks Z., Ling C. C. Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 1997; 39: 863–873, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Teh B. S., Mai W. Y., Uhl B. M., Augspurger M. E., Grant W. H., III, Lu H. H., Woo S. Y., Carpenter L. S., Chiu J. K., Butler E. B. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. Int. J. Radiat. Oncol. Biol. Phys. 2001; 49: 705–712, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Zelefsky M. J., Fuks Z., Hunt M., Yamada Y., Marion C., Ling C. C., Amols H., Venkatraman E. S., Leibel S. A. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int. J. Radiat. Oncol. Biol. Phys. 2002; 53: 1111–1116, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Teh B. S., Mai W. Y., Augspurger M. E., Uhl B. M., McGary J., Dong L., Grant W. H., III, Lu H. H., Woo S. Y., Carpenter L. S., Chiu J. K., Butler E. B. Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2001; 49: 465–472, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Amosson C. M., Teh B. S., Mai W. Y., Van T. J., Uy N. W., Grant W. H., III, Butler E. B. Acute gastrointestinal toxicity for prostate cancer treated with intensity modulated radiation therapy—a comparison of primary versus postprostatectomy IMRT. Am. Radium Soc. Abst. 2001; (Abstract #38) 7(6)534, [CSA]
  • Bastasch M. D., Teh B. S., Mai W. Y., Carpenter L. S., Lu H. H., Chiu J. K., Woo S. Y., Grant W. H., III, Miles B. J., Kadmon D., Butler E. B. Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: effect on erectile function. Int. J. Radiat. Oncol. Biol. Phys. 2002; 54: 101–106, [PUBMED], [INFOTRIEVE], [CSA]
  • Sinopoli M. T., Teh B. S., Mai W. Y., Van T. J., Chiu J. K., Carpenter L. S., Lu H. H., Woo S. Y., Grant W. H., III, Butler E. B. Analysis of biochemical control following definitive intensity-modulated radiation therapy (IMRT) alone with endorectal balloon immobilization and dose escalation for localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2002; 54(2 Supplement), 277 (#2113)
  • Kupelian P. A., Reddy C. A., Carlson T. P., Altsman K. A., Willoughby T. R. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2002; 53: 904–912, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Jack Yang C. C., Raben A., Carlson D. IMRT: high-definition radiation therapy in a community hospital. Med. Dosim. 2001; 26: 215–226, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Teh B. S., Aguilar-Cordova E., Kernen K., Chou C. C., Shalev M., Vlachaki M. T., Miles B., Kadmon D., Mai W. Y., Caillouet J., Davis M., Ayala G., Wheeler T., Brady J., Carpenter L. S., Lu H. H., Chiu J. K., Woo S. Y., Thompson T., Butler E. B. Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer—a preliminary report. Int. J. Radiat. Oncol. Biol. Phys. 2001; 51: 605–613, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Teh B. S., Aguilar-Cordova E., Vlachaki M. T., Aguilar L., Mai W. Y., Caillouet J., Davis M., Miles B., Kadmon D., Ayala G., Lu H. H., Chiu J. K., Carpenter L. S., Woo S. Y., Grant W. H., III, Wheeler T., Thompson T. C., Butler E. B. Combining radiotherapy with gene therapy (from the bench to the bedside): a novel treatment strategy for prostate cancer. Oncologist 2002; 7: 458–466, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Nutting C. M., Corbishley C. M., Sanchez-Nieto B., Cosgrove V. P., Webb S., Dearnaley D. P. Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy. Br. J. Radiol. 2002; 75: 151–161, [PUBMED], [INFOTRIEVE], [CSA]
  • Pickett B., Vigneault E., Kurhanewicz J., Verhey L., Roach M. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1999; 44: 921–929, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Rasch C., Barillot I., Remeijer P., Touw A., van Herk M., Lebesque J. V. Definition of the prostate in CT and MRI: a multi-observer study. Int. J. Radiat. Oncol. Biol. Phys. 1999; 43: 57–66, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.